scholarly journals Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy

2010 ◽  
Vol 162 (1) ◽  
pp. 24-31 ◽  
Author(s):  
T. J. Smith
Keyword(s):  
Bone Marrow ◽  
Potential Role ◽  
Thyroid Associated Ophthalmopathy ◽  
Orbital Fibroblast ◽  
Fibroblast Heterogeneity

scholarly journals Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy

2002 ◽  
Vol 87 (1) ◽  
pp. 385-392 ◽  
Author(s):  
Terry J. Smith ◽  
Laura Koumas ◽  
AnneMarie Gagnon ◽  
Andrea Bell ◽  
Gregory D. Sempowski ◽  
...  
Keyword(s):  
Clinical Presentation ◽  
Thyroid Associated Ophthalmopathy ◽  
Orbital Fibroblast ◽  
Fibroblast Heterogeneity

GCSF Partially Repairs Heart Damage Induced by Repetitive β-adrenergic Stimulation in Mice: Potential Role of the Mobilized Bone Marrow-derived Cells

2016 ◽  
Vol 12 (7) ◽  
pp. 689-700 ◽  
Author(s):  
B. Nieto-Lima ◽  
A. Cano-Marti ◽  
G. Zarco-Olve ◽  
F.A. Masso-Roja ◽  
A. Paez-Arena ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Potential Role ◽  
Adrenergic Stimulation ◽  
Heart Damage ◽  
Bone Marrow Derived Cells

Abstract 4262: NR2F1 and SOX9 mediate reprogramming of tumor cells into dormancy: Potential role in dormant bone marrow DTCs

2012 ◽  
Author(s):  
Maria S. Sosa ◽  
Yeriel Estrada ◽  
Falguni Parikh ◽  
Almudena Bosch-Gutierrez ◽  
Esther Ekpin ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Tumor Cells ◽  
Potential Role

scholarly journals Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma

2020 ◽  
Vol 21 (20) ◽  
pp. 7539
Author(s):  
Amro M. Soliman ◽  
Teoh Seong Lin ◽  
Pasuk Mahakkanukrauh ◽  
Srijit Das
Keyword(s):  
Multiple Myeloma ◽  
Bone Marrow ◽  
Tumor Growth ◽  
Malignant Transformation ◽  
Bone Disease ◽  
Clinical Management ◽  
Potential Role ◽  
Plasma Cells ◽  
The Usa

Multiple myeloma (MM) is a cancerous bone disease characterized by malignant transformation of plasma cells in the bone marrow. MM is considered to be the second most common blood malignancy, with 20,000 new cases reported every year in the USA. Extensive research is currently enduring to validate diagnostic and therapeutic means to manage MM. microRNAs (miRNAs) were shown to be dysregulated in MM cases and to have a potential role in either progression or suppression of MM. Therefore, researchers investigated miRNAs levels in MM plasma cells and created tools to test their impact on tumor growth. In the present review, we discuss the most recently discovered miRNAs and their regulation in MM. Furthermore, we emphasized utilizing miRNAs as potential targets in the diagnosis, prognosis and treatment of MM, which can be useful for future clinical management.

Sign in / Sign up

Export Citation Format

Share Document